RAM Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
5,980
-16
-0.3% -$3.44K 0.24% 39
2026
Q1
$1.3M Buy
5,996
+379
+7% +$84.1K 0.23% 38
2025
Q4
$1.28M Sell
5,617
-872
-13% -$199K 0.23% 35
2025
Q3
$1.5M Buy
6,489
+131
+2% +$26.7K 0.28% 29
2025
Q2
$1.18M Buy
6,358
+453
+8% +$84.2K 0.25% 31
2025
Q1
$1.24M Buy
5,905
+631
+12% +$123K 0.31% 28
2024
Q4
$937K Sell
5,274
-4
-0.1% -$735 0.23% 35
2024
Q3
$1.04M Buy
5,278
+59
+1% +$11K 0.27% 31
2024
Q2
$895K Buy
5,219
+59
+1% +$9.77K 0.26% 29
2024
Q1
$940K Buy
5,160
+68
+1% +$11.7K 0.3% 25
2023
Q4
$789K Buy
5,092
+53
+1% +$7.73K 0.28% 26
2023
Q3
$751K Buy
5,039
+19
+0.4% +$2.79K 0.32% 24
2023
Q2
$676K Sell
5,020
-88
-2% -$12.9K 0.28% 26
2023
Q1
$814K Sell
5,108
-213
-4% -$32.6K 0.44% 19
2022
Q4
$860K Buy
+5,321
New +$816K 0.53% 18

Other funds holding ABBV

RAM Investment Partners's ABBV Position: Q2 2026 in Review

RAM Investment Partners reduced its AbbVie (ABBV) stake by 0.27% in Q2 2026, selling an estimated $3.44K and leaving 5,980 shares worth $1.5M. The position accounts for 0.24% of the portfolio, ranked #39.

RAM Investment Partners first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,136 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RAM Investment Partners held 5,980 shares of AbbVie worth $1.5M as of Q2 2026.
  • RAM Investment Partners sold 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.24% of RAM Investment Partners's portfolio in Q2 2026, its #39 holding.
  • RAM Investment Partners first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 2,136 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RAM Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.